News & Updates
Filter by Specialty:
Whole pelvic radiation therapy improves survival in high-risk prostate cancer
Prostate cancer (PCa) patients with higher lymph node (LN) risk scores and Gleason grade who are treated with whole pelvis radiotherapy (WPRT) have better overall survival (OS), reports a study.
Whole pelvic radiation therapy improves survival in high-risk prostate cancer
02 Jun 2022
Accelerated daratumumab infusion safe, well tolerated in multiple myeloma
Accelerated administration of daratumumab, an anti-CD3 monoclonal antibody approved for multiple myeloma, is safe and well tolerated when given following at least two standard infusions, suggest the results of a recent study.
Accelerated daratumumab infusion safe, well tolerated in multiple myeloma
29 May 2022
Chemoradiotherapy improves disease control in muscle-invasive bladder cancer
Chemotherapy with 5-fluorouracil (5FU) and mitomycin C (MMC), when combined with radiotherapy, leads to better locoregional control over a 10-year window in patients with muscle-invasive bladder cancer (MIBC), a recent study has found.
Chemoradiotherapy improves disease control in muscle-invasive bladder cancer
28 May 2022
Compromised nutritional, immunological status ups infection risk after gastric cancer surgery
Infection is a common complication in gastric cancer stage II/III patients after gastrectomy, a recent study has found. A low prognostic nutritional index score seems to be an important risk factor for such an outcome.
